Utama › Myasthenia Gravis › Kansas
Kajian klinikal Myasthenia Gravis di Kansas
7 kajian untuk Myasthenia Gravis sedang mencari peserta di lokasi di Kansas.
Bandar di Kansas
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- University of Kansas Medical Center Research Institute, Inc. - 3901 Rainbow (MAIN), Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06463587Zilucoplan for Severe gMG Exacerbations
- University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07215949RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT06359041A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Jun 2026 · NCT06456580A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- University of Kansas Medical Center, Kansas City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06298565Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
- University of Kansas Clinical Research Center, Fairway
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Apr 2025 · NCT06064695Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.